Therefore, in the context of these recent publications identifying the contributory role of CDO1 as a tumor suppressor gene, our findings suggest co-option of this pathway is likely cell type–dependent and catabolism through this axis may be uniquely relevant in glioblastoma biology and its associated tumor microenvironment. The gene discussed is CDO1; the disease is neoplasm.